Thrombotic thrombocytopenic purpura classification: Difference between revisions
Jump to navigation
Jump to search
| Line 6: | Line 6: | ||
* '''Hereditary:''' Insertions, deletions, missense, nonsense point mutations and splice site mutations of both alleles of ADAMS13 genes cause decrease in the amount and activity of the enzyme. | * '''Hereditary:''' Insertions, deletions, missense, nonsense point mutations and splice site mutations of both alleles of ADAMS13 genes cause decrease in the amount and activity of the enzyme. | ||
* '''Acquired:''' | * '''Acquired:''' Existence of an inhibitory antibody against ADAMS13 due to variety of conditions. | ||
==References== | ==References== | ||
Revision as of 17:56, 6 August 2018
|
Thrombotic thrombocytopenic purpura Microchapters |
|
Differentiating Thrombotic thrombocytopenic purpura from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Thrombotic thrombocytopenic purpura classification On the Web |
|
American Roentgen Ray Society Images of Thrombotic thrombocytopenic purpura classification |
|
Thrombotic thrombocytopenic purpura classification in the news |
|
Directions to Hospitals Treating Thrombotic thrombocytopenic purpura |
|
Risk calculators and risk factors for Thrombotic thrombocytopenic purpura classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Saeedeh Kowsarnia M.D.[2]
Overview
Classification
- Hereditary: Insertions, deletions, missense, nonsense point mutations and splice site mutations of both alleles of ADAMS13 genes cause decrease in the amount and activity of the enzyme.
- Acquired: Existence of an inhibitory antibody against ADAMS13 due to variety of conditions.